A review of adverse events in animals and children after secondary exposure to transdermal hormone‐containing medicinal products

BACKGROUND: Hormonal replacement therapy is widely used to treat conditions in humans, the most well‐known indication being the relief of menopausal symptoms in women. Many of the hormone‐containing products (HCP) are applied to the skin. This transdermal delivery poses a risk to animals and humans...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjöström, Karin, Mount, James, Klocker, Anna‐Karin, Arthurson, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614385/
https://www.ncbi.nlm.nih.gov/pubmed/36320814
http://dx.doi.org/10.1002/vro2.48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614385/
https://www.ncbi.nlm.nih.gov/pubmed/36320814
http://dx.doi.org/10.1002/vro2.48

Ejemplares similares